Related Experiment Video
Updated: Aug 5, 2026
06:10
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
γδ T Cells as a Platform for Immunotherapy: From Biological Principles to Clinical Translation
Junjie Ni1, Chao Xiong1, Xian Wu1
1Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.
Immunological Investigations
|August 4, 2026
Summary
Gamma delta (γδ) T cells show promise for immunotherapy due to their unique effector functions. However, challenges like heterogeneity and limited understanding hinder their clinical application, requiring further research for optimized therapeutic design.
Area of Science:
- Immunology
- Cellular Biology
- Cancer Research
Background:
- Gamma delta (γδ) T cells possess innate-like effector functions and adaptive immune features.
- They recognize stress signals independently of MHC, making them attractive for immunotherapy.
- Significant heterogeneity in γδ T cell subsets, localization, and function currently limits their clinical utility.
Purpose of the Study:
- To review the fundamental biology of γδ T cell development, classification, and antigen recognition.
- To explore how context-dependent γδ T cell functions influence therapeutic strategies.
- To summarize current translational approaches and their limitations.
Main Methods:
- Comprehensive literature review integrating evidence on γδ T cell biology in cancer, infection, and autoimmunity.
- Evaluation of major translational strategies for γδ T cell-based therapies.
- Analysis of biological principles governing γδ T cell function and therapeutic design.
Main Results:
- Current therapeutic strategies include in vivo activation, adoptive transfer, combination regimens, engineered cells, and cell-free approaches like extracellular vesicles.
- Clinical translation is impeded by product heterogeneity, insufficient cell expansion and persistence, and incomplete mechanistic understanding.
- γδ T cells offer a versatile platform combining innate and adaptive immune characteristics.
Conclusions:
- Future γδ T cell therapy development should focus on mechanism-guided engineering and biomarker-informed strategies.
- Improved clinical study designs are crucial for advancing γδ T cell-based immunotherapies.
- Overcoming heterogeneity and mechanistic gaps is key to unlocking the full therapeutic potential of γδ T cells.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...